Research
Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial
Kenneth Rockwood, Sherri Fay, Xiaowei Song, Chris MacKnight, Mary Gorman and ; on behalf of the Video-Imaging Synthesis of Treating Alzheimer's Disease (VISTA) Investigators
CMAJ April 11, 2006 174 (8) 1099-1105; DOI: https://doi.org/10.1503/cmaj.051432
Kenneth Rockwood
Sherri Fay
Xiaowei Song
Chris MacKnight
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
CMAJ
Vol. 174, Issue 8
11 Apr 2006
Article tools
Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial
Kenneth Rockwood, Sherri Fay, Xiaowei Song, Chris MacKnight, Mary Gorman
CMAJ Apr 2006, 174 (8) 1099-1105; DOI: 10.1503/cmaj.051432
Jump to section
Related Articles
Cited By...
- Goal attainment scaling as an outcome measure for randomised controlled trials: a scoping review
- Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial
- Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia
- EFFECT OF GALANTAMINE ON VERBAL REPETITION IN AD: A SECONDARY ANALYSIS OF THE VISTA TRIAL
- Effect of galantamine on verbal repetition in AD: A secondary analysis of the VISTA trial
- Community based occupational therapy improved daily functioning in older patients with dementia
- Additional articles abstracted in ACP Journal Club
- An innovative approach to involve patients in measuring treatment effects in drug trials